FREDUN PHARMACEUTICALS
|
FREDUN PHARMACEUTICALS Last 5 Year Income Statement History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹348 Cr | ₹275 Cr | ₹224 Cr | ₹134 Cr | ₹11,277,136 Cr |
| Sales | ₹347 Cr | ₹274 Cr | ₹222 Cr | ₹131 Cr | ₹11,029,857 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹1.58 Cr | ₹0.33 Cr | ₹2.72 Cr | ₹2.41 Cr | ₹247,279 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹348 Cr | ₹275 Cr | ₹224 Cr | ₹134 Cr | ₹11,277,136 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-22 Cr | ₹-38 Cr | ₹-0.01 Cr | ₹1.17 Cr | ₹-504,274 Cr |
| Raw Material Consumed | ₹284 Cr | ₹246 Cr | ₹177 Cr | ₹101 Cr | ₹8,679,015 Cr |
| Opening Raw Materials | ₹64 Cr | ₹21 Cr | ₹36 Cr | ₹24 Cr | ₹2,133,847 Cr |
| Purchases Raw Materials | ₹300 Cr | ₹289 Cr | ₹162 Cr | ₹113 Cr | ₹8,958,847 Cr |
| Closing Raw Materials | ₹81 Cr | ₹64 Cr | ₹21 Cr | ₹36 Cr | ₹2,413,679 Cr |
| Other Direct Purchases / Brought in cost | - | - | - | - | - |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹4.47 Cr | ₹3.37 Cr | ₹3.49 Cr | ₹2.94 Cr | ₹310,166 Cr |
| Electricity & Power | ₹4.47 Cr | ₹3.37 Cr | ₹3.46 Cr | ₹2.87 Cr | ₹305,193 Cr |
| Oil, Fuel & Natural gas | - | - | ₹0.03 Cr | ₹0.07 Cr | ₹4,974 Cr |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹13 Cr | ₹12 Cr | ₹11 Cr | ₹8.66 Cr | ₹894,767 Cr |
| Salaries, Wages & Bonus | ₹11 Cr | ₹10 Cr | ₹9.59 Cr | ₹7.71 Cr | ₹794,732 Cr |
| Contributions to EPF & Pension Funds | ₹0.57 Cr | ₹0.57 Cr | ₹0.58 Cr | ₹0.51 Cr | ₹53,382 Cr |
| Workmen and Staff Welfare Expenses | ₹0.77 Cr | ₹0.51 Cr | ₹0.32 Cr | ₹0.26 Cr | ₹21,276 Cr |
| Other Employees Cost | ₹0.18 Cr | ₹0.13 Cr | ₹0.16 Cr | ₹0.17 Cr | ₹25,378 Cr |
| Other Manufacturing Expenses | ₹10 Cr | ₹7.25 Cr | ₹4.41 Cr | ₹3.13 Cr | ₹357,768 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹6.41 Cr | ₹3.75 Cr | ₹1.69 Cr | ₹0.16 Cr | ₹25,717 Cr |
| Repairs and Maintenance | ₹2.08 Cr | ₹1.74 Cr | ₹0.88 Cr | ₹0.61 Cr | ₹78,910 Cr |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | ₹1.85 Cr | ₹1.76 Cr | ₹1.84 Cr | ₹2.36 Cr | ₹253,140 Cr |
| General and Administration Expenses | ₹16 Cr | ₹11 Cr | ₹8.72 Cr | ₹5.48 Cr | ₹519,136 Cr |
| Rent , Rates & Taxes | ₹6.38 Cr | ₹5.29 Cr | ₹4.58 Cr | ₹1.56 Cr | ₹145,688 Cr |
| Insurance | ₹1.15 Cr | ₹0.69 Cr | ₹0.40 Cr | ₹0.27 Cr | ₹5,310 Cr |
| Printing and stationery | ₹0.70 Cr | ₹0.35 Cr | ₹0.23 Cr | ₹0.25 Cr | ₹24,710 Cr |
| Professional and legal fees | ₹3.35 Cr | ₹2.13 Cr | ₹1.61 Cr | ₹1.29 Cr | ₹136,431 Cr |
| Traveling and conveyance | ₹1.06 Cr | ₹1.20 Cr | ₹0.76 Cr | ₹0.37 Cr | ₹78,645 Cr |
| Other Administration | ₹3.22 Cr | ₹1.15 Cr | ₹1.14 Cr | ₹1.73 Cr | ₹128,353 Cr |
| Selling and Distribution Expenses | ₹5.07 Cr | ₹4.24 Cr | ₹5.61 Cr | ₹1.78 Cr | ₹176,020 Cr |
| Advertisement & Sales Promotion | ₹2.89 Cr | ₹1.70 Cr | ₹0.46 Cr | ₹0.11 Cr | ₹30,605 Cr |
| Sales Commissions & Incentives | - | - | ₹0.27 Cr | ₹0.07 Cr | ₹72,405 Cr |
| Freight and Forwarding | ₹2.19 Cr | ₹2.55 Cr | ₹4.84 Cr | ₹1.47 Cr | ₹67,894 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | - | - | ₹0.04 Cr | ₹0.12 Cr | ₹5,115 Cr |
| Miscellaneous Expenses | ₹0.62 Cr | ₹1.00 Cr | ₹0.56 Cr | ₹0.33 Cr | ₹11,454 Cr |
| Bad debts /advances written off | ₹0.02 Cr | ₹0.03 Cr | ₹0.31 Cr | - | - |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | - | - | - | - | - |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹0.61 Cr | ₹0.98 Cr | ₹0.25 Cr | ₹0.33 Cr | ₹11,454 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹310 Cr | ₹247 Cr | ₹211 Cr | ₹125 Cr | ₹10,444,052 Cr |
| Operating Profit (Excl OI) | ₹38 Cr | ₹28 Cr | ₹14 Cr | ₹9.35 Cr | ₹833,084 Cr |
| Other Income | ₹0.92 Cr | ₹1.82 Cr | ₹1.63 Cr | ₹1.40 Cr | ₹51,713 Cr |
| Interest Received | ₹0.01 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.03 Cr | ₹6,770 Cr |
| Dividend Received | - | ₹0.00 Cr | ₹0.00 Cr | - | ₹3.00 Cr |
| Profit on sale of Fixed Assets | - | - | - | - | - |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | - | ₹0.07 Cr | ₹6,979 Cr |
| Foreign Exchange Gains | ₹0.72 Cr | ₹1.39 Cr | ₹1.18 Cr | ₹0.06 Cr | ₹23,069 Cr |
| Others | ₹0.18 Cr | ₹0.41 Cr | ₹0.44 Cr | ₹1.24 Cr | ₹14,892 Cr |
| Operating Profit | ₹39 Cr | ₹30 Cr | ₹16 Cr | ₹11 Cr | ₹884,797 Cr |
| Interest | ₹14 Cr | ₹9.28 Cr | ₹4.78 Cr | ₹4.37 Cr | ₹447,457 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹2.52 Cr | ₹4.98 Cr | ₹3.34 Cr | ₹3.14 Cr | ₹318,835 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹1.13 Cr | ₹1.72 Cr | ₹0.39 Cr | ₹0.32 Cr | ₹33,148 Cr |
| Other Interest | ₹10 Cr | ₹2.59 Cr | ₹1.05 Cr | ₹0.91 Cr | ₹95,474 Cr |
| PBDT | ₹25 Cr | ₹20 Cr | ₹11 Cr | ₹6.37 Cr | ₹437,341 Cr |
| Depreciation | ₹3.80 Cr | ₹2.81 Cr | ₹2.16 Cr | ₹2.00 Cr | ₹187,873 Cr |
| Profit Before Taxation & Exceptional Items | ₹21 Cr | ₹18 Cr | ₹8.60 Cr | ₹4.37 Cr | ₹249,467 Cr |
| Exceptional Income / Expenses | - | - | - | ₹-1.16 Cr | - |
| Profit Before Tax | ₹21 Cr | ₹18 Cr | ₹8.60 Cr | ₹3.21 Cr | ₹249,467 Cr |
| Provision for Tax | ₹5.83 Cr | ₹6.70 Cr | ₹2.27 Cr | ₹1.19 Cr | ₹59,275 Cr |
| Current Income Tax | ₹5.54 Cr | ₹4.29 Cr | ₹2.21 Cr | ₹0.76 Cr | ₹44,394 Cr |
| Deferred Tax | ₹0.29 Cr | ₹2.41 Cr | ₹0.05 Cr | ₹0.44 Cr | ₹14,881 Cr |
| Other taxes | - | - | - | - | - |
| Profit After Tax | ₹16 Cr | ₹11 Cr | ₹6.34 Cr | ₹2.02 Cr | ₹190,192 Cr |
| Extra items | - | - | - | - | - |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹29 Cr | ₹18 Cr | ₹12 Cr | ₹10 Cr | ₹784,454 Cr |
| Appropriations | ₹44 Cr | ₹29 Cr | ₹18 Cr | ₹12 Cr | ₹974,646 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹0.40 Cr | ₹0.26 Cr | ₹0.26 Cr | ₹0.27 Cr | ₹-43,019 Cr |
| Equity Dividend % | ₹7.00 | ₹7.00 | ₹7.00 | ₹7.00 | ₹6.60 |
| Earnings Per Share | ₹33.25 | ₹23.84 | ₹14.29 | ₹5.05 | ₹4.77 |
| Adjusted EPS | ₹33.25 | ₹23.84 | ₹14.29 | ₹5.05 | ₹4.77 |
Compare Income Statement of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹743.2 Cr | -11.2% | -7.1% | 123.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | -11.2% |
-7.1% |
123.1% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses